.jpeg)
What kind of anti-tumor drug does sirolimus belong to?
Sirolimus, also a macrolide compound used to coat coronary stents, is a drug used to prevent the body from rejecting a newly transplanted kidney. It is used in adults who are at low to moderate risk of rejection. It is recommended that sirolimus be taken with cyclosporine and corticosteroids (other drugs to prevent organ rejection) for two to three months. Sirolimus may be used for continuation of corticosteroid therapy, but only if cyclosporine therapy can be discontinued. Sirolimus, which contains the active substance sirolimus, is also used to treat sporadic lymphangioleiomyomatosis (S-LAM) in patients with moderate lung disease or worsening lung function.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
